Mostrando 2 resultados de: 2
Filtros aplicados
Origen
scopus(2)
Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients
ArticleAbstract: Risperidone (R) is the most prescribed antipsychotic drug for patients with a first episode of psychPalabras claves:Antipsychotic, CYP2D6, pharmacogenetics, pharmacokineticsAutores:Adrián LLerena, Aguilar E.J., Albacete A., Alonso-Solís A., Baeza I., Balanzá-Martínez V., Balbuena A., Barcones F., Bergé D., Bernardo E.G., Bernardo M., Bioque M., Bobes J., Boloc D., Butjosa A., Castro-Fornieles J., Contreras F., Coromina M., Corripio I., Cuadrado A.I., Cuesta M.J., de la Serna E., Dompablo M., Echevarría R.S., Fraile M.G., García-Portillo M.P., Gassó P., González-Pinto A., Jimenez E., Lafuente A., Landín-Romero R., Lobo A., López P., Martínez-Cengotitabengoa M., Mas S., Morales-Muñoz I., Olmeda M.S., Parellada M., Rabella M., Rodriguez N., Rodriguez-Jimenez R., Sáiz P.A., Saiz-Ruiz J., Sanjuán J., Sarró S., Torra M., Torrent C., Usall J., Vieta E., Zapata M.Fuentes:scopusStrengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: The potential value of the PEPs study
ReviewAbstract: The successful application of pharmacogenetics in routine clinical practice is still a long way fromPalabras claves:Antipsychotic, naturalistic studies, pharmacogenetics, Pharmacogenomics, psychiatry, study designsAutores:Adrián LLerena, Bernardo M., Lafuente A., Mas S., Saíz J.Fuentes:scopus